Menu
Munasarjasyöpätutkimus toi yhteen potilaita ja tutkijoita Biomedicumissa
In English: About 60 researchers, patients, their loved ones, and citizens interested in cancer research gathered in Biomedicum on May 11 to meet and discuss the advances in ovarian cancer…
The joint statement on RDI funding from the Academy of Finland Flagship projects
iCAN supports the joint statement on RDI funding from the Academy of Finland Flagship projects. The recent long-term funding plan for RDI (March 2023) is a significant step for Finland’s competitiveness…
The figure shows homologous recombination repair marker, RAD51 (red), in high-grade serous ovarian cancer tumor cell nuclei (blue).
New tool for tailoring drug treatment in ovarian cancer
Researchers at the Universities of Helsinki and Turku have developed a test to identify those ovarian cancer patients who benefit from traditional platinum-based chemotherapy as well as from a newer…
- 1
- 2
- 3
- 4
- …
- 14
- Go to the next page